GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Teva Pharmaceutical Industries Limited (TEVA) [hlAlert]

Rating:
Buy TEVA
up 48.24 %

Teva Pharmaceutical Industries (TEVA) rated Buy

Posted on: Friday,  Sep 7, 2007  9:25 AM ET by CIBC Wrld Mkts

CIBC Wrld Mkts rated Buy Teva Pharmaceutical Industries Limited (NYSE: TEVA) on 09/07/2007, when the stock price was $43.98.
Since then, Teva Pharmaceutical Industries Limited has gained 48.25% as of 09/01/2015's recent price of $65.20.
If you would have followed this CIBC Wrld Mkts's recommendation on TEVA, you would have gained 48.24% of your investment in 2916 days.

Teva Pharmaceutical Industries Limited (Teva) is a global pharmaceutical company that develops, produces and markets generic drugs covering all treatment categories. The Company has a pharmaceutical business, whose principal products are Copaxone for multiple sclerosis and Azilect for Parkinson?s disease and respiratory products. Teva?s active pharmaceutical ingredient business provides vertical integration to Teva?s own pharmaceutical production and sells to third party manufacturers. The Company?s global operations are conducted in North America, Europe, Latin America, Asia and Israel. Teva has operations in more than 60 countries, as well as 38 finished dosage pharmaceutical manufacturing sites in 17 countries, 20 generic research and development centers operating mostly within certain manufacturing sites and 20 API manufacturing sites around the world. In January 2009, Phibro Animal Health Corporation completed the acquisition of the Abic Animal Health business from the Company.

CIBC World Markets strives to deliver leading edge investment research to investing clients through our multi-faceted, firm-wide research product offering. Our research has consistently been recognized as a top research source for its breadth of coverage, industry knowledge and quality of work in generating profitable and timely investment ideas. We provide in-depth coverage for all of the major sectors of the Canadian economy and select coverage of U.S. companies. Our analytical teams remain committed to identifying trends early and developing exploitable investment opportunities across the market capitalization spectrum. With the continued growth in quantitative and computerized investing strategies, we have also developed leading edge quantitative and technical research products to partner with our fundamental approach. Our products are available through several automated avenues: email, website, and third-party market vendors. Client service is our driving force and we constantly advance in offering greater product customization options.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/7/2007 9:25 AM Buy
None
43.98 53.00
as of 8/27/2015
1 Week down  -4.44 %
1 Month up  9.03 %
3 Months up  6.50 %
1 YTD up  62.67 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy